Understanding claims, compliance and risk in an evolving regulatory environment
As functional foods, beverages and supplements continue to gain mainstream traction, regulatory scrutiny is rising right alongside consumer demand. Ingredients like adaptogens, nootropics, botanicals and cannabinoids offer compelling benefits. But how those benefits are marketed can expose brands to significant legal and reputational risk. In today’s environment, understanding regulatory realities is no longer optional; it’s a core part of brand strategy.
Claims: where many brands get it wrong
One of the most common compliance pitfalls lies in how functional claims are framed. In the United States, the Food and Drug Administration (FDA) draws a clear distinction between structure/function claims and disease claims. While brands can describe how an ingredient supports normal bodily functions such as “supports focus” or “helps manage stress,” they cannot claim to diagnose, treat, cure or prevent disease without drug approval.
For example, saying an ingredient “supports a calm mood” may be permissible, while claiming it “treats anxiety” crosses a regulatory line. As functional formulations become more targeted, the language used in marketing, packaging and digital content must be reviewed carefully to ensure it aligns with allowable claims.
The role of substantiation and evidence
Regulators don’t just evaluate what brands say. They look at whether claims are substantiated. According to guidance from the Federal Trade Commission (FTC), advertising claims must be truthful, not misleading and backed by competent and reliable scientific evidence. This applies not only to paid advertising, but also to websites, social media, influencer partnerships and even consumer testimonials.
Organizations like the Council for Responsible Nutrition (CRN) emphasize the importance of aligning claims with ingredient dosages and existing research, rather than relying on general ingredient reputations. An ingredient supported by clinical research may still be problematic if included at a level unlikely to deliver the stated benefit.
A shifting landscape for emerging ingredients
The regulatory environment is especially complex for emerging functional ingredients. Botanicals, novel extracts and hemp-derived compounds often fall into gray areas where guidance is evolving. The FDA continues to evaluate pathways for ingredients that do not fit neatly into existing food or supplement categories, creating uncertainty for brands seeking to innovate.
In this context, proactive risk management is critical. Brands should closely monitor warning letters, enforcement trends and policy updates, as these often signal how regulators are interpreting claims in real time. Trade organizations and resources such as the International Food Information Council (IFIC) provide ongoing insight into regulatory and consumer-facing issues related to functional ingredients.
Transparency as a risk-reduction strategy
Transparency is emerging as one of the most effective tools for managing regulatory and consumer risk. Clearly disclosing ingredient sources, explaining intended benefits in plain language and avoiding exaggerated promises help build trust with both regulators and consumers. As shoppers become more educated, overstated or vague claims are more likely to trigger skepticism – and scrutiny.
Compliance as a competitive advantage
Rather than viewing regulation as a constraint, forward-thinking brands are treating compliance as a differentiator. Clear claims, strong substantiation and responsible marketing practices position brands for long-term growth in a category that is rapidly maturing. As functional products continue to move into everyday consumption occasions, brands that understand and respect the regulatory realities will be better equipped to scale, innovate and earn lasting consumer trust.
To learn more about the responsible way to market your functional ingredient beverage or product, contact the experts at Volunteer Botanicals.